Philips, Nvidia start cooperation on AI in patient care
ByAinvest
Monday, Jun 23, 2025 3:47 am ET1min read
AI--
The partnership involves integrating Nvidia's AI technology into Philips' existing healthcare products, such as imaging systems and medical devices. This integration will enable more accurate and efficient data analysis, leading to better diagnostic capabilities and treatment options for patients.
Philips and Nvidia will work together to develop AI models that can interpret medical images more effectively and provide real-time insights to healthcare professionals. The collaboration also includes the development of AI-powered medical devices that can monitor patients' vital signs and provide personalized treatment recommendations.
The partnership is a significant step forward in the adoption of AI in healthcare, as it combines Philips' extensive experience in medical technology with Nvidia's expertise in AI and computing. The collaboration is expected to lead to the development of innovative healthcare solutions that can improve patient care and reduce healthcare costs.
The collaboration comes as the healthcare industry continues to explore the potential of AI to transform patient care. The partnership between Philips and Nvidia is one of several recent collaborations between technology companies and healthcare providers aimed at leveraging AI to improve patient outcomes and operational efficiency.
References:
[1] https://www.globenewswire.com/news-release/2025/06/18/3101388/0/en/Neurona-Doses-First-Patient-in-Phase-1-2-Trial-of-NRTX-1001-Cell-Therapy-in-Adults-with-Drug-Resistant-Bilateral-Mesial-Temporal-Lobe-Epilepsy-MTLE.html
[2] https://www.digitalhealthnews.com/iqvia-launches-agentic-ai-to-boost-healthcare-workflow
[3] https://www.tweaktown.com/news/105940/nvidia-and-foxconn-discussing-the-deployment-of-humanoid-robots-to-make-ai-servers-in-usa/index.html
NVDA--
Philips, Nvidia start cooperation on AI in patient care
Amsterdam, June 19, 2025 – Philips and Nvidia have announced a strategic partnership aimed at advancing artificial intelligence (AI) in patient care. The collaboration focuses on leveraging Nvidia's AI capabilities to enhance Philips' healthcare solutions, with the goal of improving patient outcomes and operational efficiency.The partnership involves integrating Nvidia's AI technology into Philips' existing healthcare products, such as imaging systems and medical devices. This integration will enable more accurate and efficient data analysis, leading to better diagnostic capabilities and treatment options for patients.
Philips and Nvidia will work together to develop AI models that can interpret medical images more effectively and provide real-time insights to healthcare professionals. The collaboration also includes the development of AI-powered medical devices that can monitor patients' vital signs and provide personalized treatment recommendations.
The partnership is a significant step forward in the adoption of AI in healthcare, as it combines Philips' extensive experience in medical technology with Nvidia's expertise in AI and computing. The collaboration is expected to lead to the development of innovative healthcare solutions that can improve patient care and reduce healthcare costs.
The collaboration comes as the healthcare industry continues to explore the potential of AI to transform patient care. The partnership between Philips and Nvidia is one of several recent collaborations between technology companies and healthcare providers aimed at leveraging AI to improve patient outcomes and operational efficiency.
References:
[1] https://www.globenewswire.com/news-release/2025/06/18/3101388/0/en/Neurona-Doses-First-Patient-in-Phase-1-2-Trial-of-NRTX-1001-Cell-Therapy-in-Adults-with-Drug-Resistant-Bilateral-Mesial-Temporal-Lobe-Epilepsy-MTLE.html
[2] https://www.digitalhealthnews.com/iqvia-launches-agentic-ai-to-boost-healthcare-workflow
[3] https://www.tweaktown.com/news/105940/nvidia-and-foxconn-discussing-the-deployment-of-humanoid-robots-to-make-ai-servers-in-usa/index.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet